Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
about
Genome of the avirulent human-infective trypanosome--Trypanosoma rangeliDifferent serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients seraA Mother's Gift: Congenital Transmission of Trypanosoma and Leishmania SpeciesCommercial enzyme-linked immunosorbent assay versuspolymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysisNeglected tropical diseasesHigh throughput selection of effective serodiagnostics for Trypanosoma cruzi infectionThe challenges of Chagas Disease-- grim outlook or glimmer of hope.Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi.Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina.ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.A history of chagas disease transmission, control, and re-emergence in peri-rural La Joya, PeruShort-term follow-up of chagasic patients after benzonidazole treatment using multiple serological markers.High molecular weight proteins of Trypanosoma cruzi reduce cross-reaction with Leishmania spp. in serological diagnosis testsImportance of nonenteric protozoan infections in immunocompromised people.Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil.Immunological identification of Trypanosoma cruzi lineages in human infection along the endemic areaA systematic review of high quality diagnostic tests for Chagas diseaseEvaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review.Anti-Trypanosoma cruzi cross-reactive antibodies detected at high rate in non-exposed individuals living in non-endemic regions: seroprevalence and association to other viral serologiesIdentification of strain-specific B-cell epitopes in Trypanosoma cruzi using genome-scale epitope prediction and high-throughput immunoscreening with peptide arraystrans-Sialidase neutralizing antibody detection in Trypanosoma cruzi-infected domestic reservoirs.Mapping antigenic motifs in the trypomastigote small surface antigen from Trypanosoma cruzi.Improving serodiagnosis of human and canine leishmaniasis with recombinant Leishmania braziliensis cathepsin l-like protein and a synthetic peptide containing its linear B-cell epitope.Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas DiseaseHighly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic.Evaluation of in-house ELISA using Trypanosoma cruzi lysate and recombinant antigens for diagnosis of Chagas disease and discrimination of its clinical formsPosttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.Do commercial serologic tests for Trypanosoma cruzi infection detect Mexican strains in women and newborns?Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease - a Phase II study.Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas diseaseDetection of Trypanosoma cruzi infection in naturally infected dogs and cats using serological, parasitological and molecular methods.Use of Individual-level Covariates to Improve Latent Class Analysis of Trypanosoma Cruzi Diagnostic Tests.International meeting: new diagnostic tests are urgently needed to treat patients with Chagas disease.Spatial patterns in discordant diagnostic test results for Chagas disease: links to transmission hotspots.Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina.Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.Linear B-cell epitope mapping of MAPK3 and MAPK4 from Leishmania braziliensis: implications for the serodiagnosis of human and canine leishmaniasis.The efficacy of L. (L.) chagasi excreted-secreted antigens (ESAs) for visceral leishmaniasis diagnosis is due to low levels of cross-reactivity.
P2860
Q21092269-E3DBB944-0458-43CC-9EA4-78327660D27CQ21198946-CD72E541-87B9-4944-80B3-887A86FFC22FQ26773050-FF2A458B-0D09-4BD1-803F-164762ECF2EDQ26774182-9BE69929-C027-4955-8A0C-7B8FB3A77897Q28267545-B9417EE7-7A0E-44C3-AA5A-DFC6E93D69D7Q28473737-E0C08198-51CB-4D48-B6FA-D90DF8312453Q33312506-807BD20C-0E20-467A-82B4-ED45A417B16BQ33719577-DEFB0139-C5A9-47CF-A6EC-E0954C631FCFQ33738243-037E4077-E85F-48A2-BEBB-3B9BC2876DC7Q33756086-BB22ABB4-2762-470E-9390-8756F85B0474Q33834064-1E652CF1-31B3-4496-BEA5-D610047AE404Q33975717-C3D768BD-458B-4B95-9431-BC3F7C0C7EBCQ34013942-FBA9BFE2-FBC8-4AFB-91DF-26FC26707B9BQ34189873-196D0FF8-A163-40EA-91BE-1ACB8640CADCQ34194593-03D53DD9-286F-4A20-9A22-FB1C4ABA42CCQ34380196-CB50AF71-1AFA-430E-82DD-FA69D5434821Q34422237-4412C7C1-6CC2-4900-AA0F-400C88EC0872Q34474619-F3C7AC3C-A7E0-4C65-A31D-A85EB184BC40Q34992879-AB75E38C-DA75-4E67-B9A5-EC289F6961AFQ34999205-EF2635EF-286F-4684-8C1D-0718D1BF86C9Q35037072-F2C5CDB4-33A0-4354-8B8B-E81A719FA9E8Q35066452-109271DD-E25F-4B7B-AFFC-EC81630F04EFQ35122764-A799A05E-54FC-481A-904B-70C82B7738E8Q35539986-99D8D896-6664-4FE1-8550-1A28977BF9A0Q35739066-9347D69B-6052-43E1-B7FC-A597E0C645FBQ35976295-80E2BCE0-0FC4-486C-A4F9-65805106103DQ36069974-3E24B680-B3B9-459A-995E-EE0B10CC4036Q36149620-4CD702D4-6154-4A2D-8894-B9DFC21F2BF0Q36154765-6599C109-5EFC-4341-AD6F-068ECF1674F4Q36226034-04A70C4B-304D-4616-B8D2-489B2BBFFB70Q36300808-D40EC600-4C81-4377-AC62-057013A78E55Q36668496-FA47559E-3409-4CC0-B494-42674BC09FBCQ36911045-D0C221D4-D06E-4625-B080-0FCED3D9111DQ37204535-D7ECB955-2B3F-448E-B406-D83580D2C40DQ37249387-AE6D36D2-AC39-4264-8812-B52A8A7C9FBFQ37397667-995CB37C-C164-4527-9981-239B67D9D1E6Q37597055-1322F95F-280F-46CE-9A6D-92A9520E3B43Q37717875-84790C3D-CD18-40D4-BB81-6DCB9E72DF35Q38943658-606A81DB-0081-4D3B-801F-A617E20A337EQ39356937-C21E8EB3-E46A-4412-BEBC-B2BBC091901A
P2860
Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Evaluation of serological test ...... ma rangeli and Leishmania spp.
@ast
Evaluation of serological test ...... ma rangeli and Leishmania spp.
@en
type
label
Evaluation of serological test ...... ma rangeli and Leishmania spp.
@ast
Evaluation of serological test ...... ma rangeli and Leishmania spp.
@en
prefLabel
Evaluation of serological test ...... ma rangeli and Leishmania spp.
@ast
Evaluation of serological test ...... ma rangeli and Leishmania spp.
@en
P2093
P2860
P356
P1476
Evaluation of serological test ...... oma rangeli and Leishmania spp
@en
P2093
Eufrosina S Umezawa
Octavio E Sousa
Waldelania P Marques
Zuleima C Caballero
P2860
P304
P356
10.1128/CVI.00127-07
P5008
P577
2007-05-23T00:00:00Z